Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
about
Erythropoietin and Neonatal NeuroprotectionEvaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents.Neuroprotective potential of erythropoietin in neonates; design of a randomized trial.Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury.Neonatal magnesium levels correlate with motor outcomes in premature infants: a long-term retrospective cohort study.Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.Postnatal Erythropoietin Mitigates Impaired Cerebral Cortical Development Following Subplate Loss from Prenatal Hypoxia-Ischemia.Erythropoietin neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial.Preschool Assessment of Preterm Infants Treated With Darbepoetin and ErythropoietinA randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infantsRecombinant human erythropoietin improves neurological outcomes in very preterm infants.Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury.Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates.Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.Controversies in preterm brain injury.Erythropoietin Restores Long-Term Neurocognitive Function Involving Mechanisms of Neuronal Plasticity in a Model of Hyperoxia-Induced Preterm Brain Injury.Early predictors of neonatal intraventricular hemorrhage.Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.Awaiting evidence of neuroprotective effects of recombinant erythropoietin in very preterm infants.Why study erythropoietin in preterm infants?Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury.Erythropoietin protects newborn rat against sevoflurane-induced neurotoxicity.Neuroprotective Effect of Erythropoietin on Phenylhydrazine-Induced Hemolytic Hyperbilirubinemia in Neonatal Rats.Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro.Response to dr C dame.Differential short-term regional effects of early high dose erythropoietin on white matter in preterm lambs after mechanical ventilation.Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs.Chorioamnionitis, neuroinflammation, and injury: timing is key in the preterm ovine fetus.Neuroprotective Drugs in Infants With Severe Congenital Heart Disease: A Systematic Review
P2860
Q27009422-458CC90A-3475-4109-B895-D650C4B1A6B8Q30444534-AFDE701B-C49F-435C-BEA6-556B6C39920CQ31071784-0CD40331-2CF0-40E9-A20D-9D14E82C9345Q34053756-630C9AFA-A1A9-4104-A255-5672A8CF41F7Q34455033-E2836A76-F990-43AC-B079-8F967B85EF7EQ35935811-49791BC7-A4A6-45B3-84C2-761D8F9F762CQ35956626-1492A18F-4E9D-4C93-B543-CE7404EBEC4FQ36628528-D6B4EF06-7535-4BA7-89E4-577B16285E1CQ36630778-BD0EEFAB-982A-4E19-9F6F-44AD640439F5Q36952268-958A5795-1BBA-4E1F-A140-7AF329267E17Q37375616-800A5E2D-AC1D-478C-951B-E2D80C6C279DQ37396967-F1D9D98F-320B-433E-81FE-36C789F29119Q37724782-CF8FE327-BA2C-450B-BECC-778D3B5087FCQ38188856-055094B4-2A17-42B9-8DBB-1CC7A388AD67Q38255341-E1D41E71-8C45-4986-8CA4-3741B92C5E2DQ38610168-E814147D-1306-488C-96C3-615FD1C9EB89Q41775024-9FEC4F98-FD37-4AAD-BAE6-DBAB7F5364CCQ42077218-A84D4800-B238-4C72-82AB-415D4CE99F00Q42949621-92FCB828-85EB-4DE2-B1FC-E5C669B901F3Q44733105-1B620722-8337-47FD-8DD9-B31E669FE7E2Q46453494-57EBF1E0-6BD9-4636-8463-EAB553A02D9EQ47216442-DF98084A-C713-44B8-98CC-C86EF6734E20Q47885183-47FF75BE-9C96-42CE-B7E8-D6057571FB1BQ48389520-A89A6485-AE01-425C-B474-0A5B048BBE0EQ49766374-B6190905-54DC-40A5-9A2C-9C99AE7D470DQ50746707-97B5D16D-A9CA-4582-B929-32BE9C0CCE70Q51598694-4D658BD5-B33E-42B9-BDC0-94536F8D34D2Q51750586-9E48E7B3-5239-443A-9DDF-510DAE27F8E8Q52577385-6FDD9ADC-A631-4530-A948-F2CA3FD89164Q57177295-B1D23D4B-74A6-4A32-A345-4B18B193D469
P2860
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@ast
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@en
type
label
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@ast
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@en
prefLabel
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@ast
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@en
P2093
P2860
P356
P1476
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.
@en
P2093
D E Mayock
R J McPherson
R M McAdams
P2860
P2888
P304
P356
10.1038/JP.2012.78
P577
2012-06-21T00:00:00Z
P6179
1050199260